A De Novo Cause of PGM3 Deficiency Treated with Hematopoietic Stem Cell Transplantation

J Clin Immunol. 2022 Apr;42(3):691-694. doi: 10.1007/s10875-021-01196-z. Epub 2022 Jan 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunologic Deficiency Syndromes* / diagnosis
  • Immunologic Deficiency Syndromes* / genetics
  • Immunologic Deficiency Syndromes* / therapy
  • Phosphoglucomutase

Substances

  • PGM3 protein, human
  • Phosphoglucomutase